Barely Significant
← all excerpts

Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database.

Front Pharmacol · 2025 · PMC12122506 · PMID 40453668

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

a decreasing trendno p-value reported
In addition, the evaluation of the Weibull Shape Parameter analysis ( Table 4 ) showed a calculated shape parameter (β) of 0.73 with a 95% confidence interval ranging from 0.70 to 0.76, indicating a decreasing trend in the incidence of adverse effects over time, suggesting an early failure mode. 4 Discussion This study utilized data from the FAERS database to conduct a comprehensive analysis of AEs associated with vismodegib in real-world settings.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.